Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Recruiting
Observational Study
Chronic Lung Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,100 (estimated)
- Sponsor
- Medical College of Wisconsin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to determine if sequence variations in genes involved in the development and function of vulnerable organs increases susceptibility to chronic lung disease (CLD) and other diseases affecting premature infants, such as necrotizing enterocolitis (NEC), sepsis, patent ductus arteriosus (PDA) and intraventricular hemorrhage (IVH). The study will also determine whether meas…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Infants born weighing less than 1500 grams
Exclusion Criteria:
* Infants born with congenital heart disease (other than patent ductus arteriosus)
* major congenital anomalies of the GI tract, respiratory tract, or kidneys
Contacts